Expert Columns by Zachary L. Baron

post by Zachary L. Baron

Opinion & Analysis

May 13, 2025

Third Circuit Rejects Pharmaceutical Industry Challenge to Drug Negotiation Program

Opinion & Analysis

October 2, 2024

Fifth Circuit Ruling Allows Industry Challenge To Drug Negotiation Program

Opinion & Analysis

September 6, 2024

Administration Announces Medicare Negotiated Prices as Courts Continue to Reject Challenges to the Program

Opinion & Analysis

March 7, 2024

No Surprises Act Litigation: Where We Are and What Comes Next

Opinion & Analysis

October 5, 2023

Challengers to Medicare Drug Price Negotiation Program Suffer Major Defeat

Opinion & Analysis

August 31, 2023

Latest Twists and Turns in No Surprises Act Litigation: What it Means for Consumers and Ongoing Implementation

Opinion & Analysis

August 17, 2023

Policy Dispute Masquerading As Constitutional Theory? Due Process Attacks on Medicare Drug Negotiation Program

Opinion & Analysis

May 16, 2023

How Recent Litigation Undermines Efforts to Advance Health Equity in the U.S.

Opinion & Analysis

March 9, 2023

Third Circuit Issues Major Decision That Could Shift 340B Landscape

Opinion & Analysis

February 23, 2023

Continued No Surprises Act Litigation and Implications for Cost Containment Efforts

---